Unknown

Dataset Information

0

Rapid ubiquitination of Syk following GPVI activation in platelets.


ABSTRACT: Spleen tyrosine kinase (Syk) activation is a key intermediate step in the activation of platelets by the physiologic agonist collagen. We have found that Syk is rapidly ubiquitinated upon activation of platelets by collagen, collagen-related peptide (CRP), and convulxin. The Src family kinase inhibitors prevented Syk phosphorylation and its ubiquitination, indicating that the process is downstream of Src kinases. The ubiquitination of Syk did not cause degradation of the protein as evidenced by the lack of effect of proteasomal and lysosomal inhibitors. We separated ubiquitinated Syk from its nonubiquitinated counterpart and used an in vitro kinase assay to compare their activities. We found that the ubiquitinated Syk appeared to be about 5-fold more active. Using a phosphospecific antibody to Syk (Tyr525/Tyr526) that measures activated Syk, we found that most (60%-75%) of the active Syk is in the ubiquitinated fraction. This result explains the apparent high specific activity of ubiquitinated Syk. In c-Cbl-deficient mice, Syk is not ubiquitinated, implicating c-Cbl as the E3 ligase involved in Syk ubiquitination. Furthermore, Syk is not dephosphorylated in these mice. We propose that c-Cbl plays a regulatory role in glycoprotein VI (GPVI)/Fc receptor gamma (FcRgamma)-chain-dependent platelet activation through its interaction with Syk.

SUBMITTER: Dangelmaier CA 

PROVIDER: S-EPMC1895068 | biostudies-literature | 2005 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rapid ubiquitination of Syk following GPVI activation in platelets.

Dangelmaier Carol A CA   Quinter Patricia G PG   Jin Jianguo J   Tsygankov Alexander Y AY   Kunapuli Satya P SP   Daniel James L JL  

Blood 20050208 10


Spleen tyrosine kinase (Syk) activation is a key intermediate step in the activation of platelets by the physiologic agonist collagen. We have found that Syk is rapidly ubiquitinated upon activation of platelets by collagen, collagen-related peptide (CRP), and convulxin. The Src family kinase inhibitors prevented Syk phosphorylation and its ubiquitination, indicating that the process is downstream of Src kinases. The ubiquitination of Syk did not cause degradation of the protein as evidenced by  ...[more]

Similar Datasets

| S-EPMC2953889 | biostudies-other
| S-EPMC6327716 | biostudies-literature
| S-EPMC1220102 | biostudies-other
| S-EPMC2990469 | biostudies-literature
| S-EPMC2780308 | biostudies-literature
| S-EPMC5347898 | biostudies-literature
| S-EPMC6202930 | biostudies-literature
| S-EPMC6403451 | biostudies-literature
| S-EPMC8111939 | biostudies-literature
| S-EPMC5664521 | biostudies-literature